Medical Equipment

Cloning And Mutagenesis Market Revenue Growth Forecast To Reach $8.49 Billion By 2030 At 19.2% CAGR

April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Cloning And Mutagenesis Market Be By 2030 Compared To Its 2026 Market Size?

The cloning and mutagenesis market size has seen rapid expansion in recent years. Its valuation is forecast to climb from $3.54 billion in 2025 to $4.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.1%. This expansion during the historic period can be ascribed to elements such as the rise in academic research funding, the development of recombinant protein research, the growing application of genetic engineering tools, the provision of standardized molecular biology kits, and an increase in biotech startup ventures.

The cloning and mutagenesis market is projected for rapid expansion over the coming years, reaching $8.5 billion by 2030, propelled by a compound annual growth rate (CAGR) of 19.2%. This anticipated growth is primarily driven by an increasing need for gene function studies, the broadening scope of synthetic biology applications, escalating investments in developing therapeutic proteins, the wider embrace of automated laboratory platforms, and a heightened emphasis on precision genome editing. Key trends anticipated during this period involve the increasing uptake of high-fidelity cloning kits, a greater utilization of site-directed mutagenesis techniques, the surging demand for CRISPR-based editing tools, the expansion of automated molecular biology workflows, and an intensified focus on both reproducibility and accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp

What Factors Are Contributing To The Growth Of The Cloning And Mutagenesis Market?

The future expansion of the cloning and mutagenesis market is anticipated to be fueled by the rising need for personalized medicine. This innovative healthcare approach involves customizing medical treatment and interventions to suit the unique characteristics of each patient. Cloning And Mutagenesis plays crucial roles in personalized therapies, including disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, marking a substantial rise from the 6 approvals recorded in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the cloning and mutagenesis industry.

What Segment Categories Shape The Cloning And Mutagenesis Market Segment Landscape?

The cloning and mutagenesis market covered in this report is segmented –

1) By Product: Cloning Kits, Mutagenesis Kits, Other Products

2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques

3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End Users

Subsegments:

1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits

2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits

3) By Other Products: Enzymes, Vector Systems, Accessories

What Trends Are Shaping The Future Of The Cloning And Mutagenesis Market?

Key players operating within the cloning and mutagenesis markets are actively exploring advanced methodologies, such as PCR techniques, to gain a competitive advantage. Polymerase chain reaction is a laboratory procedure utilized in molecular biology to generate multiple copies of a particular DNA segment. For example, in April 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology company, launched the ID-Check Speciation Solution, a real-time PCR approach for meat speciation. This offering enables the identification of animal species present in food, feed, and environmental samples, providing a reliable and rapid means to verify raw material origins and optimize production line cleaning protocols. It targets mitochondrial DNA from various meat species, including bovine, chicken, duck, goat, horse, sheep, swine, and turkey, exhibiting exceptional sensitivity and the capacity to detect as low as 0.001% of the species DNA. The kit also integrates a duplex detection system for improved accuracy and ease of operation.

Who Are The Companies Operating Across The Cloning And Mutagenesis Market Value Chain?

Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC

Get The Full Cloning And Mutagenesis Market Report:

https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report

Where Is The Cloning And Mutagenesis Market Most Concentrated Geographically?

North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cloning And Mutagenesis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10541&type=smp

Browse Through More Reports Similar to the Global Cloning And Mutagenesis Market 2026, By The Business Research Company

Virtual Reality Vr In Medical Simulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-vr-in-medical-simulation-global-market-report

Wearable Medical Devices Market 2026

https://www.thebusinessresearchcompany.com/report/wearable-medical-devices-market

Virtual Reality Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-reality-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795